HIV-1-transgene expression in rats decreases alveolar macrophage zinc levels and phagocytosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 39, Issue 2, 2008, Pages 218-226

  Joshi, Pratibha C ^a,b   Raynor, Robert ^a   Fan, Xian ^a   Guidot, David M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

AIDS; Lung; Monocyte macrophages; Phagocytosis; Rodent

Indexed keywords

CD131 ANTIGEN; GAG PROTEIN; GLYCOPROTEIN GP 120; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; POL PROTEIN; PROTEIN SUBUNIT; TRANSACTIVATOR PROTEIN; ZINC;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; AGED; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNITY; INFECTION SENSITIVITY; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PNEUMONIA; PROTEIN EXPRESSION; PROVIRUS; RAT; TRANSGENE; ZINC DEFICIENCY;

AGING; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL LINE; CELL MEMBRANE; CHELATING AGENTS; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; CYTOPLASM; ETHYLENEDIAMINES; FEMALE; HIV-1; MACROPHAGES, ALVEOLAR; PHAGOCYTOSIS; RATS; RATS, INBRED F344; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TRANSGENES; ZINC;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS; RODENTIA;

EID: 48649084352     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0344OC     Document Type: Article

References (41)

1. Thomas C, Limper A. Pneumocystis pneumonia. N Engl J Med 2004;350:2487-2498.
2. Lin J, Nichol K. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001;161:441-446.
3. Hirschtick R, Glassroth J, Jordan M, Wilcosky T, Wallace J, Kvale P, Markowitz N, Rosen M, Mangura B, Hopewell P. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995;333:845-851.
4. Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000;117:1017-1022.
5. Thomas C, Limper A. Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat Rev Microbiol 2007;5:298-308.
6. Stebbing J, Gazzard B, Douek D. Where does HIV live? N Engl J Med 2004;350:1872-1880.
7. Pugliese A, Vidotto V, Beltramo T, Torre D. Phagocytic activity in human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 2005;12:889-895.
8. Noursadeghi M, Katz D, Miller R. HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect Dis 2006;6:794-804.
9. Klotman P, Notkins A. Transgenic models of human immunodeficiency virus type-1. Curr Top Microbiol Immunol 1996;206:197-222.
10. van Maanen M, Sutton R. Rodent models for HIV-1 infection and disease. Curr HIV Res 2003;1:121-130.
11. Bruggeman L, Dikman S, Meng C, Quaggin S, Coffman T, Klotman P. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997;100:84-92.
12. Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 2001;98:9271-9276.
13. Trapnell B. Granulocyte macrophage-colony stimulating factor augmentation therapy in sepsis: is there a role? Am J Respir Crit Care Med 2002;166:129-130.
14. Joshi P, Applewhite L, Mitchell P, Fernainy K, Roman J, Eaton D, Guidot D. GM-CSF receptor expression and signaling is decreased in lungs of ethanol-fed rats. Am J Physiol Lung Cell Mol Physiol 2006;291:1150-1158.
15. Pelaez A, Bechara R, Joshi PC, Brown LA, Guidot DM. Granulocyte/ macrophage colony-stimulating factor treatment improves alveolar epithelial barrier function in alcoholic rat lung. Am J Physiol Lung Cell Mol Physiol 2004;286:L106-L111.
16. Joshi PC, Applewhite L, Ritzenthaler J, Roman J, Fernandez A, Eaton DC, Brown LA, Guidot DM. Chronic ethanol ingestion in rats decreases granulocyte-macrophage colony-stimulating factor receptor expression and downstream signaling in the alveolar macrophage. J Immunol 2005;175:6837-6845.
17. Prasad AS. Discovery of human Zn deficiency: impact on human health. Nutrition 2001;17:685-687.
18. Zalewski PD. Zinc metabolism in the airway: basic mechanisms and drug targets. Curr Opin Pharmacol 2006;6:237-243.
19. Truong-Tran AQ, Carter J, Ruffin R, Zalewski PD. New insights into the role of zinc in the respiratory epithelium. Immunol Cell Biol 2001;79:170-177.
20. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH. Antioxidant effect of zinc in humans. Free Radic Biol Med 2004;37:1182-1190.
21. Izumi Y, Auberson YP, Zorumski CF. Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors. J Neurosci 2006;26:7181-7188.
22. Mackenzie GG, Oteiza PI. Zinc and the cycloskeleton in the neuronal modulation of transcription factor NFAT. J Cell Physiol 2007;210:246-256.
23. Prasad AS. The role of zinc in gastrointestinal and liver disease. Clin Gastroenterol 1983;12:713-741.
24. Kang YJ, Zhou Z. Zinc prevention and treatment of alcoholic liver disease. Mol Aspects Med 2005;26:391-404.
25. Scrimgeour AG, Stahl CH, McClung JP, Marchitelli LJ, Young AJ. Moderate Zn deficiency negatively affects biochemical properties of rat tibiae independently of body composition. J Nutr Biochem 2007;18:813-819.
26. Meunier N, O'Connor JM, Maiani G, Cashman KD, Secker DL, Ferry M, Roussel AM, Coudray C. Importance of zinc in the elderly: the ZENITH study. Eur J Clin Nutr 2005;59:S1-S4.
27. Joshi PC, Zhou X, Cuchens M, Jones Q. Prostaglandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common γ-chain. J Immunol 2001;166:885-891.
28. Busetto S, Trevisan E, Patriarca P, Menegazzi R. A single-step, sensitive flow cytofluorometric assay for the simultaneous assessment of membrane-bound and ingested Candida albicans in phagocytosing neutrophils. Cytometry 2004;58:201-206.
29. Jones CY, Tang AM, Forrester JE, Huang J, Hendricks KM, Knox TA, Spiegelman D, Semba RD, Woods MN. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J Acquir Immune Defic Syndr 2006;43:475-482.
30. Wellinghausen N, Kern WV, Jochle W, Kern P. Zinc serum level in human immunodeficiency virus-infected patients in relation to immunological status. Biol Trace Elem Res 2000;73:139-149.
31. Afessa B, Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU: the PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 2000;118:138-145.
32. Trapnell BC, Whitsett JA. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 2002;64:775-802.
33. Bonfield TL, Raychaudhuri B, Malur A, Abraham S, Trapnell BC, Kavuru MC, Thomassen MJ. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol 2003;285:L1132-L1136.
34. Warby TJ, Crowe SM, Jaworowski A. Human immunodeficiency virus type 1 infection inhibits granulocyte-macrophage colony stimulating factor-induced activation of STAT5A in human monocyte-derived macrophages. J Virol 2003;77:12630-12638.
35. Pittis MG, Sternik G, Sen L, Diez RA, Planes N, Pirola D, Estevez ME. Impaired phagolysosomal fusion in peripheral blood monocytes from HIV-1 infected subjects. Scand J Immunol 1993;38:423-427.
36. Wellinghausen N, Kirchner H, Rink L. The immunobiology of zinc. Immunol Today 1997;18:519-521.
37. Fischer WC, Black RE. Zinc and the risk for infectious disease. Annu Rev Nutr 2004;24:255-275.
38. Wirth JJ, Fraker PJ, Kierszenbaum F. Zinc requirement for macrophage function: effect of Zn deficiency on uptake and killing of a protozoan parasite. Immunology 1989;68:114-119.
39. Black RE. Therapeutic and preventive effects of zinc on serious childhood infectious diseases in developing countries. Am J Clin Nutr 1998;68:476S-479S.
40. Baum MK, Shor-Posner G, Campa A. Zinc status in human immunodeficiency virus infection. J Nutr 2000;130:1421S-1423S.
41. Wang Y, Liang B, Watson RR. The effect of alcohol consumption on nutritional status during murine AIDS. Alcohol 1994;11:273-278.